Identification of pathogenic GCK variants in patients with common type 2 diabetes can lead to discontinuation of pharmacological treatment

Identification of pathogenic GCK variants in patients with common type 2 diabetes can lead to discontinuation of pharmacological treatment

Background: Functionally disruptive variants in the glucokinase gene (GCK) cause a form of mild non-progressive hyperglycemia, which does not require pharmacological treatment. A substantial proportion of patients with type 2 diabetes (T2D) carry GCK variants. We aimed to investigate whether carrier...

Full description

Bibliographic Details
Main Authors:	Anne Cathrine Baun Thuesen, Rasmus Tanderup Jensen, Henrik Maagensen, Maja Refshauge Kristiansen, Henrik Toft Sørensen, Allan Vaag, Henning Beck-Nielsen, Oluf B. Pedersen, Niels Grarup, Jens Steen Nielsen, Jørgen Rungby, Anette Prior Gjesing, Heidi Storgaard, Tina Vilsbøll, Torben Hansen
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Molecular Genetics and Metabolism Reports
Subjects:	T2D (type 2 diabetes) MODY (maturity-onset diabetes of the young) Diagnosis Treatment
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214426923000186

Similar Items

Association of a homozygous GCK missense mutation with mild diabetes
by: Antonella Marucci, et al.
Published: (2019-07-01)

Incidence of HNF1A and GCK MODY Variants in a South African Population
by: Matsha TE, et al.
Published: (2020-12-01)

A synonymous variant in GCK gene as a cause of gestational diabetes mellitus
by: Natalia A. Zubkova, et al.
Published: (2019-06-01)

Studies of a genetic variant in <it>HK1 </it>in relation to quantitative metabolic traits and to the prevalence of type 2 diabetes
by: Bonnefond Amélie, et al.
Published: (2011-07-01)

Sequencing reveals protective and pathogenic effects on development of diabetes of rare GLIS3 variants.
by: Jihua Sun, et al.
Published: (2019-01-01)

Molecular genetic analysis and clinical consideration of two families with GCK gene mutation
by: WANG Zhi-xin, ZUO Qing-yao, LI Wei, CHEN Jia, DENG Wei
Published: (2020-12-01)

“Pesto” Mutation: Phenotypic and Genotypic Characteristics of Eight GCK/MODY Ligurian Patients
by: Alessandro Salina, et al.
Published: (2023-02-01)

Identification and functional analysis of GCK gene mutations in 12 Chinese families with hyperglycemia
by: Zhixin Wang, et al.
Published: (2019-07-01)

Association of GCK Gene Promoter Polymorphism and their Role in its mRNA Expression among Type 2 Diabetes Mellitus Patients
by: WASEEM FATIMA, et al.
Published: (2020-10-01)

GCK-MODY diabetes course in persons over 18 years of age: prospective observation
by: A. K. Ovsyannikova, et al.
Published: (2021-07-01)

Dairy Product Consumption Interacts with Glucokinase (GCK) Gene Polymorphisms Associated with Insulin Resistance
by: Marine S. Da Silva, et al.
Published: (2017-08-01)

Non-immune diabetes mellitus in children due to heterozygous mutations in the glucokinase gene (GCK-MODY): data of 144 patients
by: E. A. Sechko, et al.
Published: (2022-05-01)

Birth weight and length in offsprings of mothers with gestational diabetes mellitus due to mutations in GCK gene
by: Natalia A. Zubkova, et al.
Published: (2018-05-01)

MODY probability calculator for GCK and HNF1A screening in a multiethnic background population
by: Roberta Magalhães Tarantino, et al.

Correction: Does DNA Methylation of Influence Insulin Action in First Degree Relatives of Patients with Type 2 Diabetes?
by: Linn Gillberg, et al.
Published: (2013-01-01)

Influence of Insulin Receptor Single Nucleotide Polymorphisms on Glycaemic Control and Formation of Anti-Insulin Antibodies in Diabetes Mellitus
by: Laura Massarenti, et al.
Published: (2022-06-01)

Lipid profile indices in young people with GCK-MODY and HNF1A-MODY
by: Alla K. Ovsyannikova, et al.
Published: (2022-01-01)

Does DNA methylation of PPARGC1A influence insulin action in first degree relatives of patients with type 2 diabetes?
by: Linn Gillberg, et al.
Published: (2013-01-01)

Atypical hyperglycemia presentation suggests considering a diagnostic of other types of diabetes: first reported GCK-MODY in Perú
by: Juan Carlos Lizarzaburu-Robles, et al.
Published: (2020-01-01)

GCK‐MODY in pregnancy: A pregnant woman with diabetes and a small‐for‐gestational‐age fetus
by: Tiffany Tse Ling Yau, et al.
Published: (2022-12-01)

Investigating the Different Dimensions of DPP-4 Inhibitors
by: Heinz Drexel, et al.
Published: (2014-10-01)

Monogenic diabetes variants in Emirati women with gestational diabetes are associated with risk of non-autoimmune diabetes within 5 years after pregnancy
by: Hinda Daggag, et al.
Published: (2022-12-01)

Localized increases in CEPT1 and ATGL elevate plasmalogen phosphatidylcholines in HDLs contributing to atheroprotective lipid profiles in hyperglycemic GCK-MODY
by: Xiaojing Wang, et al.
Published: (2021-04-01)

Population-based studies of relationships between dietary acidity load, insulin resistance and incident diabetes in Danes
by: Joachim Gæde, et al.
Published: (2018-10-01)

Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels
by: Fan Ping, et al.
Published: (2022-10-01)

Genetic insights into fetal growth and measures of glycaemic regulation and adiposity in adulthood: a family-based study
by: Mette Hollensted, et al.
Published: (2018-12-01)

Erratum: a synonymous variant in GCK gene as a cause of gestational diabetes mellitus (diabetes mellitus. 2019;22(2). Doi: 10.14341/dm9938)
by: Natalia A. Zubkova, et al.
Published: (2019-10-01)

Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients?
by: Ele Ferrannini, et al.
Published: (2015-11-01)

GCK exonic mutations induce abnormal biochemical activities and result in GCK-MODY
by: Tongtong Dai, et al.
Published: (2023-04-01)

Association of GCK (rs1799884), GCKR (rs780094), and G6PC2 (rs560887) Gene Polymorphisms with Type 2 Diabetes among Malay Ethnics
by: Neda Ansari, et al.
Published: (2023-01-01)

Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data mining
by: Isa Kristina Kirk, et al.
Published: (2019-12-01)

Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses
by: Line Engelbrechtsen, et al.
Published: (2018-03-01)

Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia
by: Kanakamani Jeyaraman, et al.
Published: (2019-01-01)

A Novel <i>GCK</i> Large Genomic Rearrangement in a Patient with MODY-2 Detected by Clinical Exome Sequencing
by: Paola Concolino, et al.
Published: (2022-11-01)

Evaluation of Consistency of Treatment Response Across Regions—the LEADER Trial in Relation to the ICH E17 Guideline
by: Henrik K. Nielsen, et al.
Published: (2021-05-01)

Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
by: Maeng Michael, et al.
Published: (2012-10-01)

A comprehensive map of human glucokinase variant activity
by: Sarah Gersing, et al.
Published: (2023-04-01)

Management of Diabetes during School Hours: A Cross-Sectional Questionnaire Study in Denmark
by: Anne Østergaard Nannsen, et al.
Published: (2023-01-01)

Genome-wide association study of circulating levels of glucagon during an oral glucose tolerance test
by: Anna Jonsson, et al.
Published: (2021-01-01)

Co-creation of a Model for Intersectoral Health Care delivery on type II diabetes – A collaboration between patients, healthcare professionals, and researchers
by: Anne Bendix Andersen, et al.
Published: (2019-08-01)